Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4883854 | 1.00 | GABRA1 (0.43) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7175505 | 0.98 | GABRA1 (0.42) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| SCHEMBL5590407 | 0.98 | GABRA1 (0.42) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7174457 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7171333 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7183844 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7178859 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7179429 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL7177025 | 0.97 | GABRA1 (0.41) | GABRA1GABRB2CYP1A2KDM4EALOX15 | |
| SCHEMBL4535319 | 0.94 | CYP1A2 (0.40) | GABRA1GABRB2CYP1A2KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184172-B1 | HYDROSILYLATION IRON CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| US-20230265222-A1 | OLEFIN/SILOXANE INTERPOLYMERS AND OLEFIN/CYCLIC SILANE INTERPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-24 | — | — | US | disclosed |
| US-20230265222-A1 | OLEFIN/SILOXANE INTERPOLYMERS AND OLEFIN/CYCLIC SILANE INTERPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-24 | — | — | US | disclosed |
| EP-4172247-A1 | OLEFIN/SILOXANE INTERPOLYMERS AND OLEFIN/CYCLIC SILANE INTERPOLYMERS | Dow Global Technologies LLC (US) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021262774-A1 | OLEFIN/SILOXANE INTERPOLYMERS AND OLEFIN/CYCLIC SILANE INTERPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-12-30 | — | — | WO | disclosed |
| EP-2797862-B1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-10239896-B2 | Hydrosilylation iron catalyst | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2019-03-26 | — | — | US | disclosed |
| US-20170260216-A1 | HYDROSILYLATION IRON CATALYST | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| EP-3184172-A1 | HYDROSILYLATION IRON CATALYST | Kyushu University, National University Corporation (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-9586872-B2 | Olefin oligomerization methods | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-03-07 | — | — | US | disclosed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-7049442-B2 | Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins | SHELL OIL COMPANY (US) | 2006-05-23 | — | — | US | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
| US-20050159601-A1 | Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins | DE BOER ERIC J M (NL) | 2005-07-21 | — | — | US | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| EP-1325924-A1 | Chromium catalysts active in olefin polymerisation | REPSOL QUIMICA S.A. (ES) | 2003-07-09 | — | — | EP | disclosed |
| EP-1325925-A1 | Chromium catalysts active in olefin polymerization | REPSOL QUIMICA S.A. (ES) | 2003-07-09 | — | — | EP | disclosed |
| US-20030119921-A1 | Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins | SHELL OIL COMPANY | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10239896-B2 | Hydrosilylation iron catalyst | SLC40A1, FTH1, SFXN1 | GABRA1 3933/4885GABRB2 4586/4885CYP1A2 1788/4885 |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | GABRA1 3688/4885GABRB2 3686/4885CYP1A2 2390/4885 |
| US-20030119921-A1 | Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins | EBPL, ETFB, EML4 | GABRA1 2280/4885GABRB2 2708/4885CYP1A2 214/4885 |
| US-20170260216-A1 | HYDROSILYLATION IRON CATALYST | SLC40A1, FTH1, SFXN1 | GABRA1 3933/4885GABRB2 4586/4885CYP1A2 1788/4885 |
| US-20050159601-A1 | Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins | EBPL, ZC3HAV1L, EML4 | GABRA1 2020/4885GABRB2 2286/4885CYP1A2 136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.